{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:51:55Z","timestamp":1770742315789,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T00:00:00Z","timestamp":1496880000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s40257-017-0303-z","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T14:16:27Z","timestamp":1496931387000},"page":"593-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comment on: Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment"],"prefix":"10.1007","volume":"18","author":[{"given":"Philip R.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,8]]},"reference":[{"key":"303_CR1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40257-016-0239-8","volume":"18","author":"NA Vashi","year":"2017","unstructured":"Vashi NA, Wirya SA, Inyang M, Kundu RV. Facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol. 2017;18:215\u201330.","journal-title":"Am J Clin Dermatol"},{"key":"303_CR2","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/pcmr.12404","volume":"28","author":"A-Y Lee","year":"2015","unstructured":"Lee A-Y. Recent progress in melasma pathogenesis. Pigm Cell Melanoma Res. 2015;28:648\u201360.","journal-title":"Pigm Cell Melanoma Res"},{"key":"303_CR3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.5021\/ad.2015.27.6.763","volume":"27","author":"A Ogita","year":"2015","unstructured":"Ogita A, Funasaka Y, Ansai S, Kawana S, Saeki H. Melasma in a male patient due to estrogen therapy for prostate cancer. Ann Dermatol. 2015;27:763\u20134.","journal-title":"Ann Dermatol"},{"issue":"2","key":"303_CR4","first-page":"57","volume":"10","author":"A Snyder","year":"2017","unstructured":"Snyder A, Schiechert RA, Zaiac MN. Melasma associated with topical estrogen cream. J Clin Aesthet Dermatol. 2017;10(2):57\u20138.","journal-title":"J Clin Aesthet Dermatol"},{"key":"303_CR5","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/jid.2012.175","volume":"132","author":"NH Kim","year":"2012","unstructured":"Kim NH, Cheong KA, Lee TR, Lee AY. PDZK1 upregulation in estrogen-related hyperpigmentation in melasma. J Invest Dermatol. 2012;132:2622\u201331.","journal-title":"J Invest Dermatol"},{"key":"303_CR6","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1468-3083.2010.03638.x","volume":"24","author":"YH Jang","year":"2010","unstructured":"Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol Venereol. 2010;24:1312\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"303_CR7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","volume":"46","author":"EH Kim","year":"2007","unstructured":"Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111\u20136.","journal-title":"J Dermatol Sci"},{"key":"303_CR8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","volume":"27","author":"JI Na","year":"2013","unstructured":"Na JI, Choi SY, Yang SH, Choi HR, Kang HY, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2013;27:1035\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"303_CR9","first-page":"1","volume":"21","author":"B Sofen","year":"2016","unstructured":"Sofen B, Prado G, Emer J. Melasma and post inflammatory hyperpigmentation: management update and expert opinion. Skin Ther Lett. 2016;21(1):1\u20137.","journal-title":"Skin Ther Lett"},{"key":"303_CR10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40257-013-0038-4","volume":"14","author":"S Rivas","year":"2013","unstructured":"Rivas S, Pandya AG. Treatment of melasma with topical agents, peels and lasers: an evidence-based review. Am J Clin Dermatol. 2013;14:359\u201376.","journal-title":"Am J Clin Dermatol"},{"key":"303_CR11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/14764172.2016.1229485","volume":"19","author":"D Posnick","year":"2017","unstructured":"Posnick D, Dunbar S, Bloom B, Goldberg DJ. Energy based device treatment of melasma: an update and review of the literature. J Cosmet Laser Ther. 2017;19:2\u201312.","journal-title":"J Cosmet Laser Ther"},{"key":"303_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mehy.2017.01.020","volume":"101","author":"PR Cohen","year":"2017","unstructured":"Cohen PR. Melasma treatment: a novel approach using a topical agent that contains an anti-estrogen and a vascular endothelial growth factor inhibitor. Med Hypothese. 2017;101:1\u20135.","journal-title":"Med Hypothese"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-017-0303-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0303-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-017-0303-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T06:26:39Z","timestamp":1499840799000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-017-0303-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,8]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1007\/s40257-017-0303-z","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,8]]}}}